| Nicole Farley, | |
|
3 Grist Mill Ln, Simsbury, CT 06070-2485 | |
| (203) 414-3768 | |
| Not Available |
| Full Name | Nicole Farley |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 3 Grist Mill Ln, Simsbury, Connecticut |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144743204 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 005006 (Connecticut) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Nicole Farley, 3 Grist Mill Ln, Simsbury, CT 06070-2485 Ph: (203) 414-3768 | Nicole Farley, 3 Grist Mill Ln, Simsbury, CT 06070-2485 Ph: (203) 414-3768 |
News Archive
A group of tiny RNA molecules with a big role in regulating gene expression also appear to have a role in causing insulin resistance in woman with polycystic ovary syndrome and, perhaps, in all women, researchers report.
By the end of this year, colonoscopy screening will have prevented bowel cancer in approximately 99 000 people since it was introduced in Germany. This is the result obtained by Hermann Brenner of the German Cancer Research Center in Heidelberg and his co-authors in their interim assessment conducted eight years after the procedure was added to the German cancer screening program.
Seattle Genetics, Inc. and Millennium Pharmaceuticals, Inc.: The Takeda Oncology Company today announced that they have initiated a phase I clinical trial of brentuximab vedotin (SGN-35) in combination with chemotherapy for the treatment of newly diagnosed Hodgkin lymphoma patients. Brentuximab vedotin is an antibody-drug conjugate (ADC) that is also in single-agent clinical trials, including a pivotal trial for relapsed and refractory Hodgkin lymphoma and a phase II trial for systemic anaplastic large cell lymphoma.
NextBio today announced the latest evolution of its innovative life science research platform, adding new capabilities for the integration and mining of high-throughput array and next-generation sequencing data. The new NextBio Sequence-Centric module enables researchers to effectively explore and utilize massive amounts of public and internally generated sequencing data, while allowing organizations to create corporate-wide genomic data platforms to serve the needs of their global research teams.
The Center of Innovation for Nanobiotechnology (COIN) today announced the upcoming NanoBio Executive Roundtable event to be hosted at RTP Foundation in Durham, NC on May 17, 2011. This Roundtable will tackle regulatory issues surrounding nanomedicine commercialization. The "Nanomedicines and the Regulatory Path" Roundtable will kick off with a presentation from Katherine Tyner, Ph.D., a Chemist in the Center for Drug Evaluation and Research at the Food and Drug Administration (FDA).
› Verified 9 days ago
Allison Amanda Grubbs, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 45 Westwood Dr, Simsbury, CT 06070 Phone: 413-262-4734 | |
Casey Bowen, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 45 Westwood Dr, Simsbury, CT 06070 Phone: 860-608-7366 | |
Ms. Emily Hamel, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 45 Westwood Dr, Simsbury, CT 06070 Phone: 860-608-7366 | |
Catherine M Marco, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 10 Library Ln, Simsbury, CT 06070 Phone: 860-856-5751 | |
Christina L Pompeo, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 33 Phelpscroft Rd, Simsbury, CT 06070 Phone: 860-424-6558 | |
Mrs. Julie Connor Burke, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3 Grist Mill Ln, Simsbury, CT 06070 Phone: 203-414-3768 |